Clinical Trial: A Phase II Study of Low-Dose Intestinal Radiotherapy Combined with Neoadjuvant Chemotherapy and Immunotherapy for Resectable Esophageal Squamous Cell Carcinoma (China)

Posted On: 2026-11-12

China, Nov. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase II Study of Low-Dose Intestinal Radiotherapy Combined with Neoadjuvant Chemotherapy and Immunotherapy for Resectable Esophageal Squamous Cell Carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136498

Registration Time: 2026/11/11

Type: Interventional study

Primary Sponsor: Cancer Hospital of Shantou University Medical College

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=351787

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Phase II Study of Low-Dose Intestinal Radiotherapy Combined with Neoadjuvant Chemotherapy and Immunotherapy for Resectable Esophageal Squamous Cell Carcinoma (China)